PMS-LIDOCAINE VISCOUS 2% LIQUID

Ülke: Kanada

Dil: İngilizce

Kaynak: Health Canada

şimdi satın al

Ürün özellikleri Ürün özellikleri (SPC)
07-04-2016

Aktif bileşen:

LIDOCAINE HYDROCHLORIDE

Mevcut itibaren:

PHARMASCIENCE INC

ATC kodu:

N01BB02

INN (International Adı):

LIDOCAINE

Doz:

2%

Farmasötik formu:

LIQUID

Kompozisyon:

LIDOCAINE HYDROCHLORIDE 2%

Uygulama yolu:

DENTAL

Paketteki üniteler:

100,50 ML

Reçete türü:

OTC

Terapötik alanı:

LOCAL ANESTHETICS

Ürün özeti:

Active ingredient group (AIG) number: 0101280001; AHFS:

Yetkilendirme durumu:

MARKETED

Yetkilendirme tarihi:

1990-12-31

Ürün özellikleri

                                PRESCRIBING INFORMATION
PMS-LIDOCAINE VISCOUS 2%
Lidocaine Hydrochloride Oral Topical Solution, USP
20 mg/mL
Oral Topical Anesthetic
PHARMASCIENCE INC.
6111 Royalmount Ave., Suite 100
Montreal, Quebec
H4P 2T4
www.pharmascience.com
Date of Revision:
April 6, 2016
Submission Control No: 193450
_ _
_ _
_Prescribing Information ~ pms-LIDOCAINE VISCOUS 2% _
_Page 2 of 21 _
_ _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
..........................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................3
CONTRAINDICATIONS
...................................................................................................4
WARNINGS AND PRECAUTIONS
..................................................................................4
ADVERSE REACTIONS
....................................................................................................8
DRUG INTERACTIONS
....................................................................................................9
DOSAGE AND ADMINISTRATION
..............................................................................11
OVERDOSAGE
................................................................................................................13
ACTION AND CLINICAL PHARMACOLOGY
............................................................14
STORAGE AND STABILITY
..........................................................................................16
DOSAGE FORMS, COMPOSITION AND PACKAGING
.............................................16
REFERENCES
..................................................................................................................17
PART III: CONSUMER
INFORMATION...............................................................................18
_ _
_ _
_Prescribing Information ~ pms-LIDOCAINE VISCOUS 2% _
_Page 3 of 21 _
_ _
PMS-LIDOCAINE VISCOUS 
                                
                                Belgenin tamamını okuyun
                                
                            

Diğer dillerdeki belgeler

Ürün özellikleri Ürün özellikleri Fransızca 15-04-2016

Bu ürünle ilgili arama uyarıları